Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-12-17FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application from Granules Pharmaceuticals Inc. for methylphenidate hydrochloride granules, adding a new dosage f…
-
FDA approval · 2024-12-17FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)
FDA approved lisdexamfetamine dimesylate as a generic version of Vyvanse under an Original Application (ANDA) from SpecGx LLC. The product i…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: The Prevalence and Predictors of Gastrointestinal Symptoms in Children With Attention Deficit / Hyperactivity Disorder
The completed study evaluates how common gastrointestinal symptoms are in children with attention-deficit/hyperactivity disorder and identif…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence
This clinical trial update describes an ADHD remote-technology study evaluating cardiometabolic risk factors and medication adherence; the t…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial [Phase 3]
Phase 3 hybrid Type I trial evaluating telehealth-based treatment for parents with attention-deficit/hyperactivity disorder and their young …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-12-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s original application for lisdexamfetamine dimesylate, a generic version of the ADHD medication,…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Mindfulness and Cognitive Training Programs for Children with ADHD (the NeuroMind Study) [NA]
The NeuroMind Study, which investigates mindfulness and cognitive training programs for children with Attention-deficit/hyperactivity disord…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17. [NA]
A clinical trial is evaluating a novel algorithm as a diagnostic aid for attention-deficit/hyperactivity disorder in youths aged 6-17, and t…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders [NA]
This clinical trial update relates to a digital-based psychosocial intervention for parents of children with autism spectrum disorder and at…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Mobile Behavioral Parent Training for Childhood ADHD: A Micro-randomized Trial [NA]
A completed micro-randomized trial evaluating a mobile behavioral parent training program for children with Attention Deficit Hyperactivity …
-
FDA approval · 2024-11-29FDA Approved: XELSTRYM — Supplemental Application (Noven Therapeutics, LLC)
FDA approved a supplemental application for XELSTRYM (dextroamphetamine) by Noven Therapeutics, LLC.
-
FDA approval · 2024-11-29FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved the supplemental application for the Methylphenidate Transdermal System (methylphenidate) from PADAGIS US LLC. This action upda…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes [Phase 2]
A Phase 2 head-to-head clinical trial compares lisdexamfetamine and methylphenidate for ADHD in pediatric patients with Type 1 diabetes and …
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Pilot Study on a Health Promotion Intervention for Ultra-Orthodox Mothers of Children With ADHD [NA]
A pilot study evaluating a health promotion intervention for Ultra-Orthodox mothers of children with Attention-Deficit/Hyperactivity Disorde…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Pilot Study on Training Emerging Adults Skills in Navigating College [NA]
A completed pilot trial sponsored by the University of North Carolina at Chapel Hill evaluated a training program to help emerging adults wi…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Mindfulness-Based ADHD Treatment for Children: a Feasibility Study [EARLY_Phase 1]
An early-phase feasibility study assessing mindfulness-based treatment for children with ADHD has been completed. The update notes the trial…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: COMT Inhibition Among Individuals With Comorbid AUD/ADHD [Phase 2]
Phase 2 clinical trial evaluating a COMT inhibitor in individuals with co-occurring Alcohol Use Disorder and Attention Deficit Hyperactivity…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Daily Routines, Executive Functioning & ADHD [NA]
A clinical trial investigating daily routines and executive functioning in individuals with ADHD is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Refining the Shared Decision Making Process Survey in ADHD Medication Decisions
This update reports completion of a clinical trial at Massachusetts General Hospital studying a survey to refine shared decision making in A…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms [NA]
This clinical trial update from Swansea University investigates the effects of omega-3 fatty acids on neurodevelopmental symptoms and is cur…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD). [Phase 4]
This document reports an ongoing Phase 4 clinical trial evaluating Dyanavel XR for co-occurring fatigue symptoms in adults with ADHD; recrui…
-
FDA approval · 2024-11-19FDA Approved: GUANFACINE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for generic guanfacine from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2024-11-15FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Elite Laboratories, Inc.)
FDA approved the original application for lisdexamfetamine dimesylate as a generic product from Elite Laboratories, Inc., confirming regulat…
-
FDA approval · 2024-10-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for lisdexamfetamine dimesylate (ANDA 217068), allowing marketing of a generic…
-
FDA approval · 2024-10-25FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for dextroamphetamine sulfate, confirming continued approval and updating label…